Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Mar 1;36(3):447-457.
doi: 10.1097/QAD.0000000000003117.

Failure to restore CD4+ cell count associated with infection-related and noninfection-related cancer

Stina Malmström  1   2 , Philippe Wagner  2 , Aylin Yilmaz  3 , Veronica Svedhem  4 , Christina Carlander  2   4   5
Affiliations

Failure to restore CD4+ cell count associated with infection-related and noninfection-related cancer

Stina Malmström et al. AIDS. .

Abstract

Objective: To assess incidence and relative risk of cancer in Sweden, by HIV status, from 1988 to 2017.

Design: Population-based register study.

Methods: From the Swedish Total Population Register, all people born between 1940 and 2000 (n = 8 587 629), and resident in Sweden sometime 1983-2017 were identified and linked to National HIV Register InfCareHIV, National Cancer Register, and LISA database. We present incidence and adjusted hazard ratios (adjHR) of infection and noninfection-related cancer for three periods between 1988 and 2017.

Results: Incidence and relative risk of infection-related cancer decreased but remained higher in people with HIV (PWH) than in HIV-negative. The proportion attributable to infection remained higher in PWH than in HIV-negative (44 vs. 9%). Women with HIV had lower risk of infection-related cancer than men with HIV [adjusted hazard ratio (adjHR) 0.6, 95% CI 0.4-0.9], mainly driven by lower incidence of Kaposi's sarcoma (adjHR 0.1, 95% CI 0.0-0.4). Current viral suppression (adjHR 0.3, 95% CI 0.2-0.5) was associated with lower risk of infection-related cancer. Current CD4+ cell count less than 200 cells/μl was associated with both infection-related (adjHR 15.3, 95% CI 10.7-21.8) and noninfection-related cancer (adjHR 2.5, 95% CI 1.5-4.1), as was CD4+ cell count increases less than 100 cells/μl post antiretroviral therapy (ART) (infection-related cancer adjHR 6.6, 95% CI 4.2-10.6, noninfection-related cancer adjHR 2.0, 95% CI 1.2-3.3).

Conclusion: Current CD4+ cell count and failure to restore CD4+ cell count both associated with infection and noninfection-related cancer. Viral suppression associated with lower risk of infection-related cancer. Early HIV detection and early adherent ART remain essential for cancer prevention.

PubMed Disclaimer

References

    1. Hernandez-Ramirez RU, Shiels MS, Dubrow R, Engels EA. Cancer risk in HIV-infected people in the USA from 1996 to 2012: a population-based, registry-linkage study . Lancet HIV 2017; 4:e495–e504.
    1. Robbins HA, Pfeiffer RM, Shiels MS, Li J, Hall HI, Engels EA. Excess cancers among HIV-infected people in the United States . J Natl Cancer Inst 2015; 107:dju503doi-org.proxy.kib.ki.se/10.1093/jnci/dju503. - DOI
    1. de Martel C, Georges D, Bray F, Ferlay J, Clifford GM. Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis . Lancet Global health 2020; 8:e180–e190.
    1. Biological agents. Volume 100 B. A review of human carcinogens. IARC monographs on the evaluation of carcinogenic risks to humans. 2012. pp. 1–441.
    1. Ruffieux Y, Muchengeti M, Egger M, Efthimiou O, Bartels L, Olago V, et al. Immunodeficiency and cancer in 3.5 million people living with human immunodeficiency virus: the South African HIV Cancer Match Study . Clin Infect Dis 2021.

Publication types

Substances